Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年9月7日
	新闻
	Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non ... Medical Xpress A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who experienced ... 标记为不相关
	Bisphenol A exposure promotes proliferation and invasion capabilities of bladder cancer cells ScienceDirect.com ... Lung Cancer, or Bladder Cancer. Cell. (2020). E. Pellerin et al. Endocrine-disrupting effects of bisphenols on urological cancers. Environ. Res. (2021). 标记为不相关
	RYBREVANT® (amivantamab) plus LAZCLUZE® (lazertinib) - GlobeNewswire GlobeNewswire Lung cancer is Europe's biggest cancer killer, with more deaths than breast cancer and prostate cancer combined.20. The main subtypes of NSCLC are ... 标记为不相关
	Rybrevant® (Amivantamab-Vmjw) Plus Lazcluze® (Lazertinib) in Non-Small Cell Lung ... AInvest ... Lung Cancer (NSCLC) Therapy: A Chemotherapy-Free Regimen Poised to Disrupt the Oncology Market and Elevate Johnson & Johnson's Shareholder Value. 标记为不相关
	Minister: Smoking, air pollution among main causes of lung damage - Malaysiakini Malaysiakini Lung cancer also remains among top 3 cancers in Malaysia, Dzulkelfy says ... cancer, chronic obstructive pulmonary disease (COPD), asthma ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈